BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Treatment
185 results:

  • 1. cancer trend and radiotherapy utilization at a tertiary academic hospital in Malaysia.
    Gan DEH; Bustam AZ
    J Cancer Res Ther; 2024 Jan; 20(1):358-362. PubMed ID: 38554346
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Association of Metabolic Risk Factors with Advanced Adenomas in Hispanic Patients.
    Tamai R; Dawit L; Lee P; Simmons OL; Ding L; Yuan L
    Dig Dis Sci; 2024 Apr; 69(4):1403-1410. PubMed ID: 38363522
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. High intramuscular adipose tissue content associated with prognosis and postoperative complications of cancers.
    Liu R; Qiu Z; Zhang L; Ma W; Zi L; Wang K; Kuang T; Zhao K; Wang W
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2509-2519. PubMed ID: 37990969
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Efficacy of olaparib in advanced cancers with germline or somatic mutations in brca1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study.
    Joris S; Denys H; Collignon J; Rasschaert M; T'Kint de Roodenbeke D; Duhoux FP; Canon JL; Tejpar S; Mebis J; Decoster L; Aftimos P; De Grève J
    ESMO Open; 2023 Dec; 8(6):102041. PubMed ID: 37852034
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING-dependent therapy-induced senescence and provides "one-two punch" opportunity with anti-PD-L1 therapy in colorectal cancer.
    Wang T; Liu W; Shen Q; Tao R; Li C; Shen Q; Lin Y; Huang Y; Yang L; Xie G; Bai J; Li R; Wang L; Tao K; Yin Y
    Cancer Sci; 2023 Nov; 114(11):4184-4201. PubMed ID: 37702298
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Chromosomal, gestational, and neonatal outcomes of embryos classified as a mosaic by preimplantation genetic testing for aneuploidy.
    Viotti M; Greco E; Grifo JA; Madjunkov M; Librach C; Cetinkaya M; Kahraman S; Yakovlev P; Kornilov N; Corti L; Biricik A; Cheng EH; Su CY; Lee MS; Bonifacio MD; Cooper AR; Griffin DK; Tran DY; Kaur P; Barnes FL; Zouves CG; Victor AR; Besser AG; Madjunkova S; Spinella F
    Fertil Steril; 2023 Nov; 120(5):957-966. PubMed ID: 37532168
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling.
    Özdemir Z; Çevik E; Öksüzoğlu ÖBÇ; Doğan M; Ateş Ö; Esin E; Bilgetekin İ; Demirci U; Köseoğlu Ç; Topal A; Karadurmuş N; Erdem HB; Bahsi T
    Mutat Res; 2023; 827():111831. PubMed ID: 37453313
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular typing and mutational characterization of rectal neuroendocrine neoplasms.
    Duan X; Zhao M; Yin X; Mi L; Shi J; Li N; Han X; Han G; Wang J; Hou J; Yin F
    Cancer Med; 2023 Aug; 12(15):16207-16220. PubMed ID: 37387515
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Predictive value of
    Suleimanov A; Saduakassova A; Vinnikov D; Pokrovsky V; Mamyrbekova S; Daniyarova A; Kozhabek L
    F1000Res; 2022; 11():1158. PubMed ID: 37360938
    [No Abstract]    [Full Text] [Related]  

  • 10. [A Case of Rectal Neuroendocrine Carcinoma with iris Metastasis].
    Matsuo Y; Ichikawa Y; Sawada G; Takada A; Kim HM; Murakami M; Fukunaga H; Shirai S; Kondou S; Kimura H; Morita S
    Gan To Kagaku Ryoho; 2023 May; 50(5):647-649. PubMed ID: 37218331
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Germline drivers of gynecologic carcinosarcomas.
    Sia TY; Gordhandas SB; Birsoy O; Kemel Y; Maio A; Salo-Mullen E; Sheehan M; Hensley ML; Rubinstein M; Makker V; Grisham RN; O'Cearbhaill RE; Roche KL; Mueller JJ; Leitao MM; Sonoda Y; Chi DS; Abu-Rustum NR; Berger MF; Ellenson LH; Latham A; Stadler Z; Offit K; Aghajanian C; Weigelt B; Mandelker D; Liu YL
    Gynecol Oncol; 2023 Jul; 174():34-41. PubMed ID: 37149903
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal cancer.
    Badesha JK; Zhou M; Arif AA; Gill S; Speers C; Peacock M; De Vera MA; Stuart HC; Brown CJ; Donellan F; Loree JM
    Cancer Res Commun; 2023 Apr; 3(4):548-557. PubMed ID: 37035581
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Metastasis risk stratification and response prediction through dynamic viable circulating tumor cell counts for rectal cancer in a neoadjuvant setting.
    Liu WY; Zhang W; Tang Y; Chen SL; Li N; Lei JQ; Shi JM; Wang SL; Li YX; Zhang KT; Jin J
    Cancer Med; 2023 May; 12(10):11438-11450. PubMed ID: 37014817
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Relationship between PET/CT images and KRAS gene mutations in colorectal cancer in Vietnamese patients.
    Dan NV; Phuong PC; Thai PV; Nguyen NH; Loi NT; Cong BT
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1480-1486. PubMed ID: 36876696
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeting BAP1 with small compound inhibitor for colon cancer treatment.
    Kang M; Park SG; Lee SA; Kim S; Lee D; Shirbhate ME; Youn SY; Kim KM; Cha SS; Kwon J
    Sci Rep; 2023 Feb; 13(1):2264. PubMed ID: 36754982
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association of distance traveled on receipt of surgery in patients with locally advanced rectal cancer.
    Hao S; Meyer D; Klose C; Irish W; Honaker MD
    Int J Colorectal Dis; 2023 Jan; 38(1):8. PubMed ID: 36629973
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The BRCAness Landscape of cancer.
    Guo M; Wang SM
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497135
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline brca1 mutation: a case report.
    Liu Y; Zhu J; Wei X; Yang D; Li S; Qian X; Li L
    J Ovarian Res; 2022 Dec; 15(1):127. PubMed ID: 36463302
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A Previously Unrecognized Molecular Landscape of Lynch Syndrome in the Mexican Population.
    Padua-Bracho A; Velázquez-Aragón JA; Fragoso-Ontiveros V; Nuñez-Martínez PM; Mejía Aguayo ML; Sánchez-Contreras Y; Ramirez-Otero MA; De la Fuente-Hernández MA; Vidal-Millán S; Wegman-Ostrosky T; Pedroza-Torres A; Arriaga-Canon C; Herrera-Montalvo LA; Alvarez-Gómez RM
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232851
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution.
    Chen G; Gong T; Wang Z; Wang Z; Lin X; Chen S; Sun C; Zhao W; Kong Y; Ai H; Yang H; Liu Y; Wu F; Kang J; Zhao S; Xiao X; Sun J; He A; Li Z
    Cell Oncol (Dordr); 2022 Dec; 45(6):1155-1167. PubMed ID: 36136268
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.